These compounds may interact with:
Neuronal acetylcholine receptor subunit alpha-4
Potentially involved in: autosomal dominant nocturnal frontal lobe epilepsy; epilepsy; carcinoma; nicotine dependence; microphthalmia with limb anomalies; schizophrenia; alzheimer's disease; myasthenia gravis; parkinson's disease; toxic encephalopathy; pain agnosia; attention deficit hyperactivity disorder; cancer; dementia; alcohol dependence; withdrawal disorder; mal de meleda; sudden infant death syndrome; alcoholic intoxication, chronic; autistic disorder
Disease data sourced from Pharos.